Skip to content
Inicio
Login
Descubre más: busca en todos nuestros recursos
All Fields
Title
Author
Subject
Find
Advanced
🎤
A phase 1/2 study of lenalidom...
Text this
Text this:
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.
Number:
Provider:
Select your carrier
Cricket
T Mobile
Verizon
Virgin Mobile